Advanced search
Publication Cover
Drug Metabolism Reviews Volume 37, 2005 - Issue 3
Submit an article Journal homepage
479
Views
122
CrossRef citations to date
0
Altmetric
Research Article

Arylamine N-Acetyltransferases: What We Learn from Genes and Genomes

Sotiria Boukouvala Department of Molecular Biology and Genetics, Democritus University of Thrace, Alexandroupolis, Greece
&
Giannoulis Fakis Department of Molecular Biology and Genetics, Democritus University of Thrace, Alexandroupolis, Greece
Pages 511-564 | Published online: 09 Oct 2008

References

  • Abe, M., Deguchi, T., Suzuki, T. (1993). The structure and characterisation of a fourth allele of polymorphic N-acetyltransferase gene found in the Japanese population. Biochem. Biophys. Res. Commun. 191:811–816., [PUBMED], [INFOTRIEVE], [CSA]
  • Abu-Zeid, M., Nagata, K., Miyata, M., Ozawa, S., Fukuhara, M., Yamazoe, Y., Kato, R. (1991). An arylamine acetyltransferase (AT-1) from Syrian golden hamster liver: cloning, complete nucleotide sequence and expression in mammalian cells. Mol. Carcinog. 4:81–88. [PUBMED], [INFOTRIEVE], [CSA]
  • Adam, P. J., Berry, J., Loader, J. A., Tyson, K. L., Craggs, G., Smith, P., De Belin, J., Steers, G., Pezzerella, F., Sachsenmeir, K. F., Stamps, A. C., Herath, A., Sim, E., O'Hare, M. J., Harris, A. L., Terrett, J. A. (2003). Arylamine N-acetyltransferase-1 is highly expressed in breast cancers and conveys enhanced growth and resistance to etoposide in vitro. Mol. Cancer Res. 1:826–835. [PUBMED], [INFOTRIEVE], [CSA]
  • Agúndez, J. A. G., Martinez, C., Olivera, M., Ledesma, M. C., Ladero, J. M., Benitez, J. (1994). Molecular analysis of the arylamine N-acetyltransferase polymorphism in a Spanish population. Clin. Pharmacol. Ther. 56:202–209. [CSA]
  • Agúndez, J. A. G., Ladero, J. M., Olivera, M., Abildua, R., Roman, J. M., Benitez, J. (1995). Genetic analysis of the arylamine N-acetyltransferase polymorphism in breast cancer patients. Oncology 52:7–11. [CSA]
  • Agúndez, J. A. G., Menaya, J. G., Tejeda, R., Lago, F., Chavez, M., Benitez, J. (1996a). Genetic analysis of the NAT2 and CYP2D6 polymorphisms in white patients with non-insulin-dependent diabetes mellitus. Pharmacogenetics 6:465–472. [CSA]
  • Agúndez, J. A. G., Olivera, M., Ladero, J. M., Rodriguez-Lescure, A., Ledesma, M. C., Diaz-Rubio, M., Meyer, U. A., Benitez, J. (1996b). Increased risk for hepatocellular carcinoma in NAT2-slow acetylators and CYP2D6-rapid metabolisers. Pharmacogenetics 6:501–512. [CSA]
  • Agúndez, J. A. G., Olivera, M., Martinez, C., Ladero, J. M., Benitez, J. (1996c). Identification and prevalence study of 17 allelic variants of the human NAT2 gene in a white population. Pharmacogenetics 6:423–428. [CSA]
  • Agúndez, J. A. G., Jimenez-Jimenez, F. J., Luengo, A., Molina, J. A., Orti-Pareja, M., Vazquez, A., Ramos, F., Duarte, J., Coria, F., Ladero, J. M., Alvarez-Cermeno, J. C., Benitez, J. (1998a). Slow allotypic variants of the NAT2 gene and susceptibility to early-onset Parkinson's disease. Neurology 51:1587–1592. [CSA]
  • Agúndez, J. A. G., Martinez, C., Olivera, M., Gallardo, L., Ladero, J. M., Rosado, C., Prados, J., Rodriguez-Molina, J., Resel, L., Benitez, J. (1998b). Expression in human prostate of drug- and carcinogen-metabolising enzymes: association with prostate cancer risk. Br. J. Cancer 78:1361–1367. [CSA]
  • Ambrosone, C. B., Freudenheim, J. L., Graham, S., Marshall, J. R., Vena, J. E., Brasure, J. R., Michalek, A. M., Laughlin, R., Nemoto, T., Gillenwater, K. A., Shields, P. G. (1996). Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms and breast cancer risk. J. Am. Med. Assoc. 276:1494–1501. [CSA], [CROSSREF]
  • Ambrosone, C. B., Freudenheim, J. L., Sinha, R., Graham, S., Marshall, J. R., Vena, J. E., Laughlin, R., Nemoto, T., Shields, P. G. (1998). Breast cancer risk, meat consumption and N-acetyltransferase (NAT2) genetic polymorphisms. Int. J. Cancer 75:825–830. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Andres, H. H., Kolb, H. J., Schreiber, R. J., Weiss, L. (1983a). Characterisation of the active site, substrate specificity and kinetic properties of acetyl-CoA:arylamine N-acetyltransferase from pigeon liver. Biochim. Biophys. Acta 746:193–201. [PUBMED], [INFOTRIEVE], [CSA]
  • Andres, H. H., Kolb, H. J., Weiss, L. (1983b). Purification and physical-chemical properties of acetyl-CoA:arylamine N-acetyltransferase from pigeon liver. Biochim. Biophys. Acta 746:182–192. [PUBMED], [INFOTRIEVE], [CSA]
  • Atmane, N., Dairou, J., Paul, A., Dupret, J. M., Rodriguez-Lima, F. (2003). Redox regulation of the human xenobiotic metabolizing enzyme arylamine N-acetyltransferase 1 (NAT1). Reversible inactivation by hydrogen peroxide. J. Biol. Chem. 278:35086–35092. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Badawi, A. F., Hirvonen, A., Bell, D. A., Lang, N. P., Kadlubar, F. F. (1995). Role of aromatic amine acetyltransferases, NAT1 and NAT2, in carcinogen-DNA adduct formation in the human urinary bladder. Cancer Res. 15:5230–5237. [CSA]
  • Bakayev, V. V., Mohammadi, F., Bahadori, M., Sheikholslami, M., Javeri, A., Masjedi, M. R., Velayati, A. A. (2004). Arylamine N-acetyltransferase 2 slow acetylator polymorphisms in unrelated Iranian individuals. Eur. J. Clin. Pharmacol. 60:467–471. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Barrett, J. H., Smith, G., Waxman, R., Gooderham, N., Lightfoot, T., Garner, R. C., Augustsson, K., Wolf, C. R., Bishop, D. T., Forman, D. (2003). Investigation of interaction between N-acetyltransferase 2 and heterocyclic amines as potential risk factors for colorectal cancer. Carcinogenesis 24:275–282. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Bell, D. A., Badawi, A. F., Lang, N. P., Ilett, K. F., Hirvonen, A. (1995a). Polymorphism in the N-acetyltransferase (NAT1) polyadenylation signal: association of the NAT1*10 allele with higher N-acetylation activity in bladder and colon tissue. Cancer Res. 55:5226–5229. [PUBMED], [INFOTRIEVE], [CSA]
  • Bell, D. A., Stephens, E. A., Castranio, T., Umbach, D. M., Watson, M., Deakin, M., Elder, J., Hendrickse, C., Duncan, H., Strange, R. C. (1995b). Polyadenylation polymorphism in the acetyltransferase 1 gene (NAT1) increases risk of colorectal cancer. Cancer Res. 55:3537–3542. [PUBMED], [INFOTRIEVE], [CSA]
  • Bell, D. A., Taylor, J. A., Butler, M. A., Stephens, E. A., Wiest, J., Brubaker, L. H., Kadlubar, F. F., Lucier, G. W. (1993). Genotype/phenotype discordance for human arylamine N-acetyltransferase (NAT2) reveals a new slow-acetylator allele common in African-Americans. Carcinogenesis 14:1689–1692. [PUBMED], [INFOTRIEVE], [CSA]
  • Bhakta, S., Besra, G. S., Upton, A. M., Parish, T., Sholto-Douglas-Vernon, C., Gibson, K. J., Knutton, S., Gordon, S., DaSilva, R. P., Anderton, M. C., Sim, E. (2004). Arylamine N-acetyltransferase is required for synthesis of mycolic acids and complex lipids in Mycobacterium bovis BCG and represents a novel drug target. J. Exp. Med. 199:1191–1199. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Bigler, J., Chen, C., Potter, J. D. (1997). Determination of human NAT2 acetylator genotype by oligonucleotide ligation assay. BioTechniques 22:682–690. [PUBMED], [INFOTRIEVE], [CSA]
  • Blum, M., Grant, D., Demierre, A., Meyer, U. A. (1989a). Nucleotide sequence of a full-length cDNA for arylamine N-acetyltransferase from rabbit liver. Nucleic Acids Res. 17:3589. [PUBMED], [INFOTRIEVE], [CSA]
  • Blum, M., Grant, D. M., Demierre, A., Meyer, U. A. (1989b). N-acetylation pharmacogenetics: a gene deletion causes absence of arylamine N-acetyltransferase in liver of slow acetylator rabbits. Proc. Natl. Acad. Sci. U. S. A. 86:9554–9557. [PUBMED], [INFOTRIEVE], [CSA]
  • Blum, M., Grant, D. M., McBride, W., Heim, M., Meyer, U. A. (1990). Human N-acetyltransferase genes: isolation, chromosomal localisation and functional expression. DNA Cell Biol. 9:193–203. [PUBMED], [INFOTRIEVE], [CSA]
  • Blum, M., Demierre, A., Grant, D. M., Heim, M., Meyer, U. (1991). Molecular mechanism of slow acetylation of drugs and carcinogens in humans. Proc. Natl. Acad. Sci. U. S. A. 88:5237–5241. [PUBMED], [INFOTRIEVE], [CSA]
  • Boissy, R. J., Watson, M. A., Umbach, D. M., Deakin, M., Elder, J., Strange, R. C., Bell, D. A. (2000). A pilot study investigating the role of NAT1 and NAT2 polymorphisms in gastric adenocarcinoma. Int. J. Cancer 87:507–511. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Boukouvala, S., Sim, E. (2005). Structural analysis of the genes for human arylamine N-acetyltransferases and characterization of alternative transcripts. Basic Clin. Pharmacol. Toxicol. 96:343–351. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Boukouvala, S., Price, N., Sim, E. (2002). Identification and functional characterization of novel polymorphisms associated with the genes for arylamine N-acetyltransferases in mice. Pharmacogenetics 12:385–394. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Boukouvala, S., Price, N., Plant, K. E., Sim, E. (2003). Structure and transcriptional regulation of the Nat2 gene encoding for the drug-metabolising enzyme arylamine N-acetyltransferase type 2 in mice. Biochem. J. 375:593–602. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Brockmöller, J., Cascorbi, I., Kerb, R., Roots, I. (1996). Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase and cytochrome P450 enzymes as modulators of bladder cancer risk. Cancer Res. 56:3915–3925., [CSA]
  • Brocvielle, H., Muret, P., Goydadin, A. C., Boone, P., Broly, F., Kantelip, J. P., Humbert, P. (2003). N-acetyltransferase 2 acetylation polymorphism: prevalence of slow acetylators does not differ between atopic dermatitis patients and healthy subjects. Skin Pharmacol. Appl. Skin Physiol. 16:386–392. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Brooke, E. W., Davies, S. G., Mulvaney, A. W., Okada, M., Pompeo, F., Sim, E., Vickers, R. J., Westwood, I. M. (2003a). Synthesis and in vitro evaluation of novel small molecule inhibitors of bacterial arylamine N-acetyltransferases (NATs). Bioorg. Med. Chem. Lett. 13:2527–2530. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Brooke, E. W., Davies, S. G., Mulvaney, A. W., Pompeo, F., Sim, E., Vickers, R. J. (2003b). An approach to identifying novel substrates of bacterial arylamine N-acetyltransferases. Bioorg. Med. Chem. 11:1227–1234. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Bruhn, C., Brockmöller, J., Cascorbi, I., Roots, I., Borchert, H.-H. (1999). Correlation between genotype and phenotype of the human arylamine N-acetyltransferase type 1 (NAT1). Biochem. Pharmacol. 58:1759–1764. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Bunschoten, A., Tiemersma, E., Schouls, L., Kampman, E. (2000). Simultaneous determination of polymorphism in N-acetyltransferase 1 and 2 genes by reverse line blot hybridisation. Anal. Biochem. 285:156–162. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Butcher, N. J., Ilett, K. F., Minchin, R. F. (1998). Functional polymorphism of the arylamine N-acetyltransferase type 1 gene caused by C190T and G560A mutations. Pharmacogenetics 8:67–72. [PUBMED], [INFOTRIEVE], [CSA]
  • Butcher, N. J., Boukouvala, S., Sim, E., Minchin, R. F. (2002). Pharmacogenetics of the arylamine N-acetyltransferases. Pharmacogenomics J. 2:30–42. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Butcher, N. J., Arulpragasam, A., Pope, C., Minchin, R. F. (2003). Identification of a minimal promoter sequence for the human N-acetyltransferase type I gene that binds AP-1 (activator protein 1) and YY-1 (Yin and Yang 1). Biochem. J. 376:441–448. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Butcher, N. J., Arulpragasam, A., Goh, H. L., Davey, T., Minchin, R. F. (2004a). Human arylamine N-acetyltransferase-1 interacts with EHZF, a multi-functional transcription co-factor. In: Third International Workshop on Arylamine N-acetyltransferases. Vancouver, Canada.
  • Butcher, N. J., Arulpragasam, A., Goh, H. L., Davey, T., Minchin, R. F. (2005). Genomic organization of human arylamine N-acetyltransferase type I reveals alternative promoters that generate different 5′-UTR splice variants with altered translational activities. Biochem. J. 387:119–127, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Butcher, N. J., Arulpragasam, A., Minchin, R. F. (2004b). Proteasomal degradation of N-acetyltransferase 1 is prevented by acetylation of the active site cysteine: a mechanism for the slow acetylator phenotype and substrate-dependent down-regulation. J. Biol. Chem. 279:22131–22137. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Cao, W., Chau, B., Hunter, R., Strnatka, D., McQueen, C. A., Erickson, R. P. (2005). Only low levels of exogenous N-acetyltransferase can be achieved in transgenic mice. Pharmacogenetics J. 5:255–261. [CSA], [CROSSREF]
  • Cartwright, R. A., Glashan, R. W., Rogers, H. J., Ahmad, R. A., Barham-Hall, D., Higgins, E., Kahn, M. A. (1982). The role of N-acetyltransferase phenotype in bladder carcinogenesis: a pharmacogenetic epidemiological approach to bladder cancer. Lancet 2:842–846. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Cascorbi, I., Drakoulis, N., Brockmöller, J., Maurer, A., Sperling, K., Roots, I. (1995). Arylamine N-acetyltransferase (NAT2) mutations and their allelic linkage in unrelated caucasian individuals: correlation with phenotypic activity. Am. J. Hum. Genet. 57:581–592. [PUBMED], [INFOTRIEVE], [CSA]
  • Cascorbi, I., Brockmöller, J., Bauer, S., Reum, T., Roots, I. (1996). NAT2*12A (803A(G) codes for rapid arylamine N-acetylation in humans. Pharmacogenetics 6:257–259. [PUBMED], [INFOTRIEVE], [CSA]
  • Cascorbi, I., Roots, I., Brockmöller, J. (2001). Association of NAT1 and NAT2 polymorphisms to urinary bladder cancer: significantly reduced risk in subjects with NAT1*10. Cancer Res. 61:5051–5056. [PUBMED], [INFOTRIEVE], [CSA]
  • Cebeza-Arvelaiz, Y., Spulveda, J. L., Lebovitz, R. M., Thompson, T. C., Chinault, A. C. (2001). Functional identification of LZTS1 as a candidate prostate tumour suppressor gene on human chromosome 8p22. Oncogene 20:4169–4179. [CSA], [CROSSREF]
  • Chan, D. K., Lam, M. K., Wong, R., Hung, W. T., Wilcken, D. E. (2003). Strong association between N-acetyltransferase 2 genotype and PD in Hong Kong Chinese. Neurology 60:1002–1005. [PUBMED], [INFOTRIEVE], [CSA]
  • Chang, F. C., Chung, J. G., Chang, W. C., Wu, L. T., Chen, G. W., Chang, S. H. (1997). Arylamine N-acetyltransferase activity in Staphylococcus aureus. J. Microbiol. Immunol. Infect. 30:170–181. [CSA]
  • Chang-Claude, J., Kropp, S., Jager, B., Bartsch, H., Risch, A. (2002). Differential effect of NAT2 on the association between active and passive smoke exposure and breast cancer risk. Cancer Epidemiol. Biomark. Prev. 11:698–704. [CSA]
  • Chen, J., Stampfer, M. J., Hough, H. L., Garcia-Closas, M., Willett, W. C., Hennekens, C. H., Kelsey, K. T., Hunter, D. J. (1998). A prospective study of N-acetyltransferase genotype, red meat intake, and risk of colorectal cancer. Cancer Res. 58:3307–3311. [PUBMED], [INFOTRIEVE], [CSA]
  • Chen, G. W., Hung, C. F., Chang, S. H., Lin, J. G., Chung, J. G. (1999). Purification and characterization of an arylamine N-acetyltransferase from Lactobacillus acidophilus. Microbios 98:159–174. [PUBMED], [INFOTRIEVE], [CSA]
  • Chiang, P.-W., Zhang, R., Stubbs, L., Zhang, L., Zhu, L., Kurnit, D. M. (1998). Comparison of murine Supt4h and a nearly identical expressed, processed gene: evidence of sequence conservation through gene conversion extending into the untranslated regions. Nucleic Acids Res. 26:4960–4964. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Chung, J. G. (1998). Purification and characterization of an arylamine N-acetyltransferase from the bacteria Aeromonas hydrophilia. Curr. Microbiol. 37:70–73. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Chung, J. G., Levy, G. N., Weber, W. W. (1993). Distribution of 2-aminofluorene and p-aminobenzoic acid N-acetyltransferase activity in the tissues of C57BL/6J rapid and B6.A-NatS slow acetylator congenic mice. Drug Metab. Dispos. 21:1057–1063. [PUBMED], [INFOTRIEVE], [CSA]
  • Chung, J. G., Kuo, H. M., Lin, T. H., Ho, C. C., Lee, J. H., Lai, J. M., Levy, G. N., Weber, W. W. (1996). Evidence for arylamine N-acetyltransferase in the nematode Anisakis simplex. Cancer Lett. 106:1–8. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Chung, J. G., Lee, J. H., Ho, C. C., Lai, J. M., Chou, Y. C., Teng, H. H., Hung, C. F., Huang, S. C. (1997a). A survey of arylamine N-acetyltransferase activity in common fruits and vegetables. J. Food Biochem. 20:481–490. [CSA]
  • Chung, J. G., Wang, H. H., Tsou, M. F., Hsieh, S. E., Lo, H. H., Yen, Y. S., Chang, S. S., Wu, L. T., Lee, J. H., Hung, C. F. (1997b). Evidence for arylamine N-acetyltransferase activity in the bacterium Helicobacter pylori. Toxicol. Lett. 91:63–71. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Cooper, G. S., Treadwell, E. L., Dooley, M. A., St Clair, E. W., Gilkeson, G. S., Taylor, J. A. (2004). N-acetyltransferase genotypes in relation to risk of developing systemic lupus erythematosus. J. Rheumatol. 31:76–80. [PUBMED], [INFOTRIEVE], [CSA]
  • Cornish, V. A., Pinter, K., Boukouvala, S., Johnson, N., Labrousse, C., Payton, M., Priddle, H., Smith, A. J., Sim, E. (2003). Generation and analysis of mice with a targeted disruption of the arylamine N-acetyltransferase type 2 gene. Pharmacogenomics J. 3:169–177. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Coughtrie, M. W. H., Sharp, S., Maxwell, K., Innes, N. P. (1998). Biology and function of the reversible sulfation pathway catalysed by human sulfotransferases and sulfatases. Chem.-Biol. Interact. 109:3–27. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Crabtree, M. D., Fletcher, C., Churchman, M., Hodgson, S. V., Neale, K., Phillips, R. K., Tomlison, I. P. (2004). Analysis of candidate modifier loci for the severity of colonic familial adenomatous polyposis, with evidence for the importance of the N-acetyltransferases. Gut 53:271–276. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Cribb, A. E., Grant, D. M., Miller, M. A., Spielberg, S. P. (1991). Expression of monomorphic arylamine N-acetyltransferase (NAT1) in human leucocytes. J. Pharmacol. Exp. Ther. 259:1241–1246., [PUBMED], [INFOTRIEVE], [CSA]
  • Dairou, J., Atmane, N., Dupret, J. M., Rodriguez-Lima, F. (2003). Reversible inhibition of the human xenobiotic-metabolising enzyme arylamine N-acetyltransferase 1 by S-nitrosothiols. Biochem. Biophys. Res. Commun. 307:1059–1065. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • De Leon, J. H., Martell, K. J., Vatsis, K. P., Weber, W. W. (1995). Slow acetylation in mice is caused by a labile and catalytically impaired mutant N-acetyltransferase (NAT2 9). Drug Metab. Dispos. 23:1354–1361. [PUBMED], [INFOTRIEVE], [CSA]
  • De Leon, J. H., Vatsis, K. P., Weber, W. W. (2000). Characterisation of naturally occuring and recombinant human N-actyltransferase variants encoded by NAT1*. Mol. Pharmacol. 58:288–299. [PUBMED], [INFOTRIEVE], [CSA]
  • Debiec-Rychter, M., Land, S. J., King, C. M. (1999). Histological localisation of acetyltransferases in human tissue. Cancer Lett. 143:99–102. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Deguchi, T. (1992). Sequences and expression of alleles of polymorphic arylamine N-acetyltransferase of human liver. J. Biol. Chem. 267:18140–18147. [PUBMED], [INFOTRIEVE], [CSA]
  • Deguchi, T., Mashimo, M., Suzuki, T. (1990). Correlations between acetylator phenotypes and genotypes of polymorphic arylamine N-acetyltransferase in human liver. J. Biol. Chem. 265:12757–12760. [PUBMED], [INFOTRIEVE], [CSA]
  • Deitz, A. C., Zheng, W., Leff, M. A., Gross, M., Wen, W. Q., Doll, M. A., Xiao, G. H., Folsom, A. R., Hein, D. W. (2000). N-acetyltransferase-2 genetic polymorphism, well-done meat intake, and breast cancer risk among postmenopausal women. Cancer Epidemiol. Biomark. Prev. 9:905–910. [CSA]
  • Delgoda, R., Lian, L. Y., Sandy, J., Sim, E. (2003). NMR investigation of the catalytic mechanism of arylamine N-acetyltransferase from Salmonella typhimurium. Biochim. Biophys. Acta 1620:8–14. [PUBMED], [INFOTRIEVE], [CSA]
  • Deloménie, C., Sica, L., Grant, D. M., Krishnamoorthy, R., Dupret, J.-M. (1996). Genotyping of the polymorphic N-acetyltransferase (NAT2*) gene locus in two native African populations. Pharmacogenetics 6:177–185. [CSA]
  • Deloménie, C., Fouix, S., Longuemaux, S., Brahimi, N., Bizet, C., Picard, B., Denamur, E., Dupret, J. M. (2001). Identification and functional characterisation of arylamine N-acetyltransferases in eubacteria: evidence for highly selective acetylation of 5-aminosalicylic acid. J. Bacteriol. 183:3417–3427. [CSA], [CROSSREF]
  • Doll, M. A., Hein, D. W. (1995). Cloning, sequencing and expression of NAT1 and NAT2 encoding genes from rapid and slow acetylator inbred rats. Pharmacogenetics 5:247–251. [PUBMED], [INFOTRIEVE], [CSA]
  • Doll, M. A., Hein, D. W. (2001). Comprehensive human NAT2 genotype method using single nucleotide polymorphism-specific polymerase chain reaction primers and fluorogenic probes. Anal. Biochem. 288:106–108. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Doll, M. A., Hein, D. W. (2002). Rapid genotype method to distinguish frequent and/or functional polymorphisms in human N-acetyltransferase-1. Anal. Biochem. 301:328–332. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Doll, M. A., Fretland, A. J., Deitz, A. C., Hein, D. W. (1995). Determination of human NAT2 acetylator genotype by restriction fragment length polymorphism and allele specific amplification. Anal. Biochem. 231:412–420. [CSA], [CROSSREF]
  • Doll, M. A., Jiang, W., Deutz, A. C., Rustan, T. D., Hein, D. W. (1997). Identification of a novel allele at the human NAT1 acetyltransferase locus. Biochem. Biophys. Res. Commun. 233:584–591. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Dupret, J.-M., Grant, D. M. (1992). Site-derected mutagenesis of recombinant human arylamine N-acetyltransferase expressed in Escherichia coli; evidence for direct involvement of Cys68 in the catalytic mechanism of polymorphic human NAT2. J. Biol. Chem. 267:7381–7385. [PUBMED], [INFOTRIEVE], [CSA]
  • Dupret, J.-M., Goodfellow, G. H., Janezic, S. A., Grant, D. M. (1994). Structure-function studies of human arylamine N-acetyltransferases NAT1 and NAT2; functional analysis of recombinant NAT1/NAT2 chimaeras expressed in Escherichia coli. J. Biol. Chem. 269:26830–26835. [PUBMED], [INFOTRIEVE], [CSA]
  • Ebisawa, T., Deguchi, T. (1991). Structure and restriction fragment length polymorphism of genes for human liver arylamine N-acetyltransferases. Biochem. Biophys. Res. Commun. 177:1252–1257. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Ebisawa, T., Sasaki, Y., Deguchi, T. (1995). Complementary DNAs for two arylamine N-acetyltransferases with identical 5′ non-coding regions from rat pineal gland. Eur. J. Biochem. 228:129–137. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Edwalds-Gilbert, G., Veraldi, K. L., Milcarek, C. (1997). Althernative poly(A) site selection in complex transcription units: means to an end? Nucleic Acids Res. 25:2547–2561. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Estrada-Rodgers, L., Levy, G. N., Weber, W. W. (1998a). Characterisation of a hormone response element in the mouse N-acetyltransferase 2 (Nat2*) promoter. Gene Expr. 7:13–24. [PUBMED], [INFOTRIEVE], [CSA]
  • Estrada-Rodgers, L., Levy, G. N., Weber, W. W. (1998b). Substrate selectivity of mouse N-acetyltransferase 1, 2, and 3 expressed in COS-1 cells. Drug Metab. Dispos. 26:502–505. [PUBMED], [INFOTRIEVE], [CSA]
  • Fakis, G., Boukouvala, S., Buckle, V., Payton, M., Denning, C., Sim, E. (2000). Chromosomal localisation and mapping of the genes for murine arylamine N-acetyltransferases (NATs), enzymes involved in the metabolism of carcinogens: identification of a novel upstream non-coding exon for murine Nat2. Cytogenet. Cell Genet. 90:134–138. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Fang, S. H., Chung, J. G., Chang, W. C., Chang, S. S. (1997). Evidence for arylamine N-acetyltransferase activity in the fungi Candida albicans. Toxicol. Lett. 92:109–116. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Farrington, S. M., Cunningham, C., Boyle, S. M., Wyllie, A. H., Dunlop, M. G. (1996). Detailed physical and deletion mapping of 8p with isolation of YAC clones from tumour suppressor loci involved in colorectal cancer. Oncogene 12:1803–1808. [PUBMED], [INFOTRIEVE], [CSA]
  • Ferguson, R. J., Doll, M. A., Rustan, T. D., Baumstark, B. R., Hein, D. W. (1994a). Syrian hamster monomorphic N-acetyltransferase (NAT1) alleles: amplification, cloning, sequencing, and expression in E. coli. Pharmacogenetics 4:82–90. [PUBMED], [INFOTRIEVE], [CSA]
  • Ferguson, R. J., Doll, M. A., Rustan, T. D., Gray, K., Hein, D. W. (1994b). Cloning, expression and functional characterisation of two mutant (NAT2191 and NAT2341/803) and wild-type human polymorphic N-acetyltransferase (NAT2) alleles. Drug Metab. Dispos. 22:371–376. [PUBMED], [INFOTRIEVE], [CSA]
  • Ferguson, R. J., Doll, M. A., Rustan, T. D., Hein, D. W. (1996). Cloning, expression and functional characterisation of rapid and slow acetylator polymorphic N-acetyltransferase encoding genes of the Syrian hamster. Pharmacogenetics 6:55–66. [PUBMED], [INFOTRIEVE], [CSA]
  • Filiadis, I. F., Georgiou, I., Alamanos, Y., Kranas, V., Giannakopoulos, X., Lolis, D. (1999). Genotypes of N-acetyltransferase-2 and risk of bladder cancer: a case-control study. J. Urol. 161:1672–1675. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Floss, H. G., Yu, T.-W. (1999). Lessons from the rifamycin biosynthetic gene cluster. Curr. Opin. Chem. Biol. 3:592–597. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Franke, S., Klowitz, I., Schnakenberg, E., Rommel, B., Van de Ven, W., Bullerdiek, J., Schloot, W. (1994). Isolation and mapping of a cosmid clone containing the human NAT2 gene. Biochem. Biophys. Res. Commun. 199:52–55. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Fretland, A. J., Doll, M. A., Gray, K., Feng, Y., Hein, D. (1997). Cloning, sequencing and recombinant expression of NAT1, NAT2 and NAT3 derived from the C3H/HeJ (rapid) and A/HeJ (slow) acetylator inbred mouse: functional characterisation of the activation and deactivation of aromatic amine carcinogens. Toxicol. Appl. Pharmacol. 142:360–366. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Fretland, A. J., Leff, M. A., Doll, M. A., Hein, D. W. (2001). Functional characterisation of human N-acetyltransferase 2 (NAT2) single nucleotide polymorphisms. Pharmacogenetics 11:207–215. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Fretland, A. J., Doll, M. A., Zhu, Y., Smith, L., Leff, M. A., Hein, D. W. (2002). Effect of nucleotide substitutions in N-acetyltransferase-1 on N-acetylation (deactivation) and O-acetylation (activation) of arylamine carcinogens: implications for cancer predisposition. Cancer Detec. Prev. 26:10–14. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Frymoyer, J. W., Jacox, R. F. (1963). Studies of genetically controlled sulfadiazine acetylation in rabbit livers: possible identification of the heterozygous trait. J. Lab. Clin. Med. 62:905–909., [PUBMED], [INFOTRIEVE], [CSA]
  • Fujiwara, Y., Emi, M., Ohata, H., Kato, Y., Nakajima, T., Mori, T., Nakamura, Y. (1993). Evidence for the presence of two tumour suppressor genes on chromosome 8p for colorectal carcinoma. Cancer Res. 53:1172–1174. [PUBMED], [INFOTRIEVE], [CSA]
  • Gaikovitch, E. A., Cascorbi, I., Mrozikiewicz, P. M., Brockmöller, J., Frotschl, R., Kopke, K., Garloff, T., Chernov, J. N., Roots, I. (2003). Polymorphisms of drug-metabolising enzyme CYP2C9, CYP2C19, CYP2D6, CYP1A1, NAT2 and of P-glycoprotein in a Russian population. Eur. J. Clin. Pharmacol. 59:303–312. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Gawronska-Szklarz, B., Luszawska-Kutrzeba, T., Czaja-Bulsa, G., Kurzawski, G. (1999). Relationship between acetylation polymorphism and risk of atopic diseases. Clin. Pharmacol. Ther. 65:562–569. [PUBMED], [INFOTRIEVE], [CSA]
  • Gertig, D. M., Hankinson, S. E., Hough, H., Spiegelman, D., Colditz, G. A., Willett, W., Kelsey, K. T., Hunter, D. J. (1999). N-acetyltransferase 2 genotypes, meat intake and breast cancer risk. Int. J. Cancer 80:13–17. [PUBMED], [INFOTRIEVE], [CSA]
  • Geylan, Y. S., Dizbay, S., Guray, T. (2001). Arylamine N-acetyltransferase activities in human breast cancer tissues. Neoplasma 48:108–111. [PUBMED], [INFOTRIEVE], [CSA]
  • Giannakopoulos, X., Charalabopoulos, K., Baltogiannis, D., Chatzikiriakidou, A., Alamanos, Y., Georgiou, I., Evangelou, A., Agnantis, N., Sofikitis, N. (2002). The role of N-acetyltransferase-2 and glutathione S-transferase on the risk and aggressiveness of bladder cancer. Anticancer Res. 22:3801–3804. [PUBMED], [INFOTRIEVE], [CSA]
  • Glowinski, I. B., Weber, W. W. (1982). Biochemical characterisation of genetically variant aromatic amine N-acetyltransferases in A/J and C57BL/6J mice. J. Biol. Chem. 257:1431–1437. [PUBMED], [INFOTRIEVE], [CSA]
  • Golka, K., Prior, V., Blaszkewicz, M., Bolt, H. M. (2002). The enhanced bladder cancer susceptibility of NAT2 slow acetylators towards aromatic amines: a review considering ethnic differences. Toxicol. Lett. 128:229–241. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Gonzalez, F. J., Kimura, S. (2001). Understanding the role of xenobiotic-metabolism in chemical carcinogenesis using gene knockout mice. Mutat. Res. 477:79–87. [PUBMED], [INFOTRIEVE], [CSA]
  • Gonzalez, M. V., Alvarez, V., Pello, M. F., Menendez, M. J., Suarez, C., Coto, E. (1998). Genetic polymorphism of N-acetyltransferase-2, glutathione S-transferase-M1, and cytochromes P450IIE1 and P450IID6 in the susceptibility to head and neck cancer. J. Clin. Pathol. 51:294–298. [PUBMED], [INFOTRIEVE], [CSA]
  • Goodfellow, G. H., Dupret, J.-M., Grant, D. M. (2000). Identification of amino acids imparting acceptor substrate selectivity to human arylamine acetyltransferases NAT1 and NAT2. Biochem. J. 348:159–166. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Grant, D. M. (1993). Molecular genetics of N-acetyltransferases. Pharmacogenetics 3:45–50. [PUBMED], [INFOTRIEVE], [CSA]
  • Grant, D. M., Blum, M., Beer, M., Meyer, U. A. (1991). Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes. Mol. Pharmacol. 39:184–191. [PUBMED], [INFOTRIEVE], [CSA]
  • Green, M. D., Tephly, T. R. (1998). Glucuronidation of amine substrates by purified and expressed UDP-glucuronosyltransferase proteins. Drug Metab. Dispos. 26:860–867. [PUBMED], [INFOTRIEVE], [CSA]
  • Green, J., Banks, E., Berrington, A., Darby, S., Deo, H., Newton, R. (2000). N-acetyltransferase 2 and bladder cancer: an overview and consideration of the evidence for gene-environment interaction. Br. J. Cancer 83:412–417. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Gross, M., Kruisselbrink, T., Anderson, K., Lang, N., McGovern, P., Delongchamp, R., Kadlubar, F. (1999). Distribution and concordance of N-acetyltransferase genotype and phenotype in an American population. Cancer Epidemiol. Biomark. Prev. 8:683–692. [CSA]
  • Guo, Z., Wagner, C. R., Hanna, P. E. (2004). Mass spectrometric investigation of the mechanism of inactivation of hamster arylamine N-acetyltransferase 1 by N-hydroxy-2-acetylaminofluorene. Chem. Res. Toxicol. 17:275–286. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Güray, T., Güvenç, T. (1997). Characterisation of sheep liver N-acetyltransferase. Biochem. Arch. 13:107–111., [CSA]
  • Hahn, M., Hagedorn, G., Kuhlisch, E., Schackert, H. K., Eckelt, U. (2002). Genetic polymorphisms of drug-metabolising enzymes and susceptibility to oral cavity cancer. Oral Oncol. 38:486–490. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Hamasaki, T., Inatomi, H., Katoh, T., Aono, H., Ikuyama, T., Muratani, T., Matsumoto, T. (2003). N-acetyltransferase-2 gene polymorphism as a possible biomarker for prostate cancer in Japanese men. Int. J. Urol. 10:167–173. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Hamdy, S. I., Hiratsuka, M., Narahara, K., Endo, N., El-Enany, M., Moursi, N., Ahmed, M. S., Mizugaki, M. (2003). Genotype and allele frequencies of TPMT, NAT2, GST, SULT1A1 and MDE-1 in the Egyptian population. Br. J. Clin. Pharmacol. 55:560–569. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Hanna, P. E. (1996). Metabolic activation and detoxification of arylamines. Curr. Med. Chem. 3:195–210. [CSA]
  • Harhangi, B. S., Oostra, B. A., Heutink, P., van Duijn, C. M., Hofman, A., Breteler, M. M. B. (1999). N-acetyltransferase-2 polymorphism in Parkinson's disease: the Rotterdam study. J. Neurol. Neurosurg. Psychiatry 67:518–520. [PUBMED], [INFOTRIEVE], [CSA]
  • Hawkins, G. A., Mychaleckyj, J. C., Zheng, S. L., Faith, D. A., Kelly, B., Isaacs, S. D., Wiley, K. E., Chang, B. L., Ewing, C. M., Bujnovszky, P., Bleecker, E. R., Walsh, P. C., Meyers, D. A., Isaacs, W. B., Xu, J. (2002). Germline sequence variants of the LZTS1 gene are associated with prostate cancer risk. Cancer Genet. Cytogenet. 137:1–7. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Hayes, R. B., Bi, W., Rothman, N., Broly, F., Caporaso, N., Feng, P., You, X., Yin, S., Woosley, R. L., Meyer, U. A. (1993). N-acetylation phenotype and genotype and risk of bladder cancer in benzidine-exposed workers. Carcinogenesis 14:675–678. [PUBMED], [INFOTRIEVE], [CSA]
  • Hearse, D. J., Weber, W. W. (1973). Multiple N-acetyltransferases and drug metabolism: tissue distribution, characterisation and significance of mammalian N-acetyltransferase. Biochem. J. 132:519–526. [PUBMED], [INFOTRIEVE], [CSA]
  • Hein, D. W. (2002). Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis. Mutat. Res. 506–507:65–77. [CSA]
  • Hein, D. W., Omichinski, J. G., Brewer, J. A., Weber, W. W. (1982). A unique pharmacogenetic expression of the N-acetylation polymorphism in the inbred hamster. J. Pharmacol. Exp. Ther. 220:8–15. [PUBMED], [INFOTRIEVE], [CSA]
  • Hein, D. W., Trinidad, A., Yerokun, T., Ferguson, R. J., Kirlin, W. G., Weber, W. W. (1988). Genetic control of acetyl coenzyme A-dependent arylamine N-acetyltransferase, hydrazine N-acetyltransferase, and N-hydroxy-arylamine O-acetyltransferase enzymes in C57BL/6J, A/J, AC57F1, and the rapid and slow acetylator A.B6 and B6.A congenic inbred mouse. Drug Metab. Dispos. 16:341–347. [PUBMED], [INFOTRIEVE], [CSA]
  • Hein, D. W., Rustan, T. D., Bucher, K. D., Martin, W. J., Furman, E. J. (1991). Acetylator phenotype-dependent and –independent expression of arylamine N-acetyltransferase isoenzymes in rapid and slow acetylator inbred rat liver. Drug Metab. Dispos. 19:933–937. [PUBMED], [INFOTRIEVE], [CSA]
  • Hein, D. W., Ferguson, R. J., Doll, M. A., Rustan, T. D., Gray, K. (1994). Molecular genetics of human polymorphic N-acetyltransferase: enzymatic analysis of 15 recombinant wild-type, mutant and chimeric NAT2 allozymes. Hum. Mol. Genet. 3:729–734. [PUBMED], [INFOTRIEVE], [CSA]
  • Hein, D. W., Doll, M. A., Fretland, A. J., Leff, M. A., Webb, S. J., Xiao, G. H., Devanaboyina, U.-S., Nangju, N. A., Feng, Y. (2000a). Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiol. Biomark. Prev. 9:29–42. [CSA]
  • Hein, D. W., Grant, D. M., Sim, E. (2000b). Update on consensus arylamine N-acetyltransferase gene nomenclature. Pharmacogenetics 10:291–292. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Hein, D. W., McQueen, C. A., Grant, D. M., Goodfellow, G. H., Kadlubar, F. F., Weber, W. W. (2000c). Pharmacogenetics of the arylamine N-acetyltransferases: a symposium in honor of Wendell W. Weber. Drug Metab. Dispos. 28:1425–1432. [PUBMED], [INFOTRIEVE], [CSA]
  • Hein, D. W., Leff, M. A., Ishibe, N., Sinha, R., Frazier, H. A., Doll, M. A., Xiao, G. H., Weinrich, M. C., Caporaso, N. E. (2002). Association of prostate cancer with rapid N-acetyltransferase 1 (NAT1*10) in combination with slow acetyltransferase 2 acetylator genotypes in a pilot case-control study. Environ. Mol. Mutagen. 40:161–167. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Henning, S., Cascorbi, I., Münchow, B., Jahnke, V., Roots, I. (1999). Association of arylamine N-acetyltransferases NAT1 and NAT2 genotypes to laryngeal cancer risk. Pharmacogenetics 9:103–111. [PUBMED], [INFOTRIEVE], [CSA]
  • Hickman, D., Sim, E. (1991). N-acetyltransferase polymorphism: comparison of phenotype and genotype in humans. Biochem. Pharmacol. 42:1007–1014. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Hickman, D., Risch, A., Buckle, V., Spurr, N. K., Jeremiah, S. J., McCarthy, A., Sim, E. (1994). Chromosomal localisation of human genes for arylamine N-acetyltransferase. Biochem. J. 297:441–445. [PUBMED], [INFOTRIEVE], [CSA]
  • Hickman, D., Palamanda, J. R., Unadkat, J. D., Sim, E. (1995). Enzyme kinetic properties of human recombinant arylamine N-acetyltransferase 2 allotypic variants expressed in Escherichia coli. Biochem. Pharmacol. 50:697–703. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Hickman, D., Pope, J., Patil, S. D., Fakis, G., Smelt, V., Stanley, L. A., Payton, M., Unadkat, J. D., Sim, E. (1998). Expression of arylamine N-acetyltransferase in human intestine. Gut 42:402–409. [PUBMED], [INFOTRIEVE], [CSA]
  • Ho, C. C., Lin, T. H., Lai, Y. S., Chung, J. G., Levy, G. N., Weber, W. W. (1996). Kinetics of acetyl coenzyme A: arylamine N-acetyltransferase from rapid and slow acetylator frog tissues. Drug Metab. Dispos. 24:137–141. [PUBMED], [INFOTRIEVE], [CSA]
  • Hou, S.-M., Ryberg, D., Fält, S., Deverill, A., Tefre, T., Børresen, A.-L., Haugen, A., Lambert, B. (2000). GSTM1 and NAT2 polymorphisms in operable and non-operable lung cancer patients. Carcinogenesis 21:49–54. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Hsieh, S. E., Lo, H. H., Chen, Y. S., Chung, J. G. (1997). The effect of vitamin C on N-acetyltransferase activity in Klebsiella pneumoniae. Food Chem. Toxicol. 35:1151–1157. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Hsieh, F.-I., Pu, Y.-S., Chern, H.-D., Hsu, L.-I., Chiou, H.-Y., Chen, C.-J. (1999). Genetic polymorphisms of N-acetyltransferase 1 and 2 and risk of cigarette smoking-related bladder cancer. Br. J. Cancer 81:537–541. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Huang, C.-S., Chern, H.-D., Shen, C.-Y., Hsu, S.-M., Chang, K.-J. (1999). Association between N-acetyltransferase 2 (NAT2) genetic polymorphism and development of breast cancer in post-menopausal Chinese women in Taiwan, an area of great increase in breast cancer incidence. Int. J. Cancer 82:175–177. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Huang, Y. S., Chern, H. D., Wu, J. C., Chao, Y., Huang, Y. H., Chang, F. Y., Lee, S. D. (2003). Polymorphism of the N-acetyltransferase 2 gene, red meat intake and the susceptibility of hepatocallular carcinoma. Am. J. Gastroenterol. 98:1417–1422. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Hubbard, A. L., Harrison, D. J., Moyes, C., Wyllie, A. H., Cunningham, C., Manion, E., Smith, C. A. D. (1997). N-acetyltransferase 2 genotype in colorectal cancer and selective gene retention in cancers with chromosome 8p deletions. Gut 41:229–234. [PUBMED], [INFOTRIEVE], [CSA]
  • Hubbard, A., Moyes, C., Wyllie, A. H., Smith, C. A. D., Harisson, D. J. (1998). N-acetyltransferase 1: two polymorphisms in coding sequence identified in colorectal cancer patients. Br. J. Cancer 77:913–916. [PUBMED], [INFOTRIEVE], [CSA]
  • Hughes, N. C., Janezic, S. A., McQueen, K. L., Jewett, M. A. S., Castranio, T., Bell, D. A., Grant, D. M. (1998). Identification and characterisation of variant alleles of human acetyltransferase NAT1 with defective function using p-aminosalicylate as an in-vivo and in-vitro probe. Pharmacogenetics 8:55–66. [PUBMED], [INFOTRIEVE], [CSA]
  • Hung, R. J., Boffetta, P., Brennan, P., Malaveille, C., Hautefeuille, A., Donato, F., Gelatti, U., Spaliviero, M., Placidi, D., Carta, A., Scotto di Carlo, A., Porru, S. (2004). GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high-risk population. Int. J. Cancer 110:598–604. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Hunter, D. J., Hankinson, S. E., Hough, H., Gertig, D. M., Garcia-Closas, M., Spiegelmn, D., Manson, J. A. E., Colditz, G. A., Willett, W. C., Speizer, F. E., Kelsey, K. (1997). A prospective study of NAT2 acetylation genotype, cigarette smoking and risk of breast cancer. Carcinogenesis 18:2127–2132. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Husain, A., Barker, D. F., States, J. C., Doll, M. A., Hein, D. W. (2004). Identification of the major promoter and non-coding exons of the human arylamine N-acetyltransferase 1 gene (NAT1). Pharmacogenetics 14:397–406. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Ilett, K. F., Ingram, D. M., Carpenter, D. S., Teitel, C. H., Lang, N. P., Kadlubar, F. F., Minchin, R. F. (1994). Expression of monomorphic and polymorphic N-acetyltransferases in human colon. Biochem. Pharmacol. 47:914–917. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Ilett, K. F., Kadlubar, F. F., Minchin, R. F. (1999). 1998 International meeting on the arylamine N-acetyltransferases: synopsis of the workshop on nomenclature, biochemistry, molecular biology, interspecies comparisons and role in human disease risk. Drug Metab. Dispos. 27:957–959. [PUBMED], [INFOTRIEVE], [CSA]
  • Inatomi, H., Katoh, T., Kawamoto, T., Matsumoto, T. (1999). NAT2 gene polymorphism as a possible marker for susceptibility to bladder cancer in Japanese. Int. J. Urol. 6:446–454. [PUBMED], [INFOTRIEVE], [CSA]
  • International Human Genome Sequencing Consortium. (2001). Initial sequencing and analysis of the human genome. Nature 409:860–921. [CSA], [CROSSREF]
  • Ishii, H., Vecchione, A., Murakumo, Y., Baldassarre, G., Numata, S., Trapasso, F., Alder, H., Baffa, R., Croce, C. M. (2001). FEZ1/LZTS1 gene at 8p22 suppresses cancer cell growth and regulates mitosis. Proc. Natl. Acad. Sci. U. S. A. 98:10374–10379. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Jaskula-Sztul, R., Skolowski, W., Gajecka, M., Szyfter, K. (2001). Association of arylamine N-acetyltransferase (NAT1 and NAT2) genotypes with urinary bladder cancer risk. J. Appl. Genet. 42:223–231. [PUBMED], [INFOTRIEVE], [CSA]
  • Jencks, W. P., Gresser, M., Valenzuela, M. S., Huneeus, F. C. (1972). Acetyl coenzyme A: arylamine acetyltransferase. Measurement of the steady state concentration of the acetyl-enzyme intermediate. J. Biol. Chem. 247:3756–3760. [PUBMED], [INFOTRIEVE], [CSA]
  • Jenne, J. W. (1965). Partial purification and properties of the isoniazid trans-acetylase in human liver. Its relationship to the acetylation of p-aminosalicylic acid. J. Clin. Invest. 44:1992–2002. [CSA]
  • Johns, L. E., Houlston, R. S. (2000). N-acetyltransferase-2 and bladder cancer risk: a meta-analysis. Environ. Mol. Mutagen. 36:221–227. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Johnson, N., Bell, P., Jonovska, V., Budge, M., Sim, E. (2004). NAT gene polymorphism and susceptibility to Alzheimer's disease: identification of a novel NAT1 allelic variant. BMC Med. Genet. 5:6. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Jorge-Nebert, L. F., Eichelbaum, M., Griese, E. U., Inaba, T., Arias, T. D. (2002). Analysis of six SNPs of NAT2 in Ngawbe and Embera Amerindians of Panama and determination of the Embera acetylation phenotype using caffeine. Pharmacogenetics 12:39–48. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Jourenkova-Mironova, N., Wikman, H., Bouchardy, C., Mitrunen, K., Dayer, P., Benhamou, S., Hirvonen, A. (1999). Role of N-acetyltransferase 1 and 2 (NAT1 and NAT2) genoypes in susceptibility to oral/pharyngeal and laryngeal cancers. Pharmacogenetics 9:533–537. [PUBMED], [INFOTRIEVE], [CSA]
  • Juberg, D. R., Bond, J. T., Weber, W. W. (1991). N-acetylation of aromatic amines: genetic polymorphism in inbred rat strains. Pharmacogenetics 1:50–57. [PUBMED], [INFOTRIEVE], [CSA]
  • Karolyi, J., Erickson, R. P., Liu, S. (1988). Genetics of susceptibility to 6-aminonicotinamide-induced cleft palate in the mouse: studies in congenic and recombinant inbred strains. Teratology 37:283–287. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Karolyi, J., Erickson, R. P., Liu, S., Killewald, L. (1990). Major effects on teratogen-induced facial clefting in mice determined by a single genetic region. Genetics 126:201–205. [PUBMED], [INFOTRIEVE], [CSA]
  • Katoh, T., Kaneko, S., Boissy, R., Watson, M., Ikemura, K., Bell, D. A. (1998). A pilot study testing the association between N-acetyltransferase 1 and 2 and risk of oral squamous cell cacinoma in Japanese people. Carcinogenesis 19:1803–1807. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Katoh, T., Inatomi, H., Yang, M., Kawamoto, T., Matsumoto, T., Bell, D. A. (1999). Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) genes and risk of urothelial transitional cell carcinoma among Japanese. Pharmacogenetics 9:401–404. [PUBMED], [INFOTRIEVE], [CSA]
  • Katoh, T., Boissy, R., Nagata, N., Kitagawa, K., Kuroda, Y., Itoh, H., Kawamoto, T., Bell, D. A. (2000). Inherited polymorphism in the N-acetyltransferase 1 (NAT1) and 2 (NAT2) genes and susceptibility to gastric and colorectal adenocarcinoma. Int. J. Cancer 85:46–49. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Kawamura, A., Sandy, J., Upton, A., Noble, M., Sim, E. (2003). Structural investigation of mutant Mycobacterium smegmatis arylamine N-acetyltransferase: a model for a naturally occurring functional polymorphism in Mycobacterium tuberculosis arylamine N-acetyltransferase. Protein Expr. Purif. 27:75–84. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Kelly, S. L., Sim, E. (1994). Arylamine N-acetyltransferase in Balb/c mice: identification of a novel mouse isoenzyme by cloning and expression in vitro. Biochem. J. 302:347–353. [PUBMED], [INFOTRIEVE], [CSA]
  • Kiss, I., Sándor, J., Ember, I. (2000). Allelic polymorphism of GSTM1 and NAT2 genes modifies dietary-induced DNA damage in colorectal mucosa. Eur. J. Cancer Prev. 9:429–432. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Kloth, M. T., Gee, R. L., Messing, E. M., Swaminathan, S. (1994). Expression of N-acetyltransferase (NAT) in cultured human uroepithelial cells. Carcinogenesis 15:2781–2787. [PUBMED], [INFOTRIEVE], [CSA]
  • Knowles, M. A. (1999). Identification of novel bladder tumour suppressor genes. Electrophoresis 20:269–279. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Knowles, M. A., Shaw, M. E., Proctor, A. J. (1993). Deletion mapping of chromosome 8 in cancers of the urinary bladder using restriction fragment length polymorphism and microsatelite polymorphisms. Oncogene 8:1357–1364. [PUBMED], [INFOTRIEVE], [CSA]
  • Kocabas, N. A., Sardas, S., Cholerton, S., Daly, A. K., Karakaya, A. E. (2004). N-acetyltransferase (NAT2) polymorphism and breast cancer susceptibility: a lack of association in a case-control study of Turkish population. Int. J. Toxicol. 23:25–31. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Kontani, K., Kawakami, M., Nakajima, T., Katsuyama, T. (2001). Tobacco use and occupational exposure to carcinogens, but not N-acetyltransferase 2 genotypes are major risk factors for bladder cancer in the Japanese. Urol. Res. 29:199–204. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Krajinovic, M., Ghadirian, P., Richer, C., Sinnett, H., Gandini, S., Perret, C., Lacroix, A., Labuda, D., Sinnett, D. (2001). Genetic susceptibility to breast cancer in French-Canadians: role of carcinogen-metabolising enzymes and gene-environment interactions. Int. J. Cancer 92:220–225. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Labuda, D., Krajinovic, M., Richer, C., Skoll, A., Sinnett, H., Yotova, V., Sinnett, D. (1999). Rapid detection of CYP1A1, CYP2D6 and NAT variants by multiplex polymerase chain reaction and allele-specific oligonucleotide assay. Anal. Biochem. 275:84–92. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Lammer, E. J., Shaw, G. M., Iovannisci, D. M., Van Waes, J., Finnell, R. H. (2004). Maternal smoking and the risk for orofacial clefts: susceptibility with NAT1 and NAT2 polymorphisms. Epidemiology 15:150–156. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Land, S. J., Jones, R. E., King, C. M. (1994). Biochemical and genetic analysis of two acetyltransferases from hamster tissues that can metabolise aromatic amine derivatives. Carcinogenesis 15:1585–1595. [PUBMED], [INFOTRIEVE], [CSA]
  • Lang, N. P., Butler, M. A., Massengill, J., Lawson, M., Stotts, R. C., Hauer-Jensen, M., Kadlubar, F. F. (1994). Rapid metabolic phenotypes for acetyltransferase and cytochrome P4501A2 and putative exposure to food-borne heterocyclic amines increase the risk for colorectal cancer or polyps. Cancer Epidemiol. Biomark. Prev. 3:675–682. [CSA]
  • Le Marchand, L., Hankin, J. H., Wilkens, L. R., Pierce, L. M., Franke, A., Kolonel, L. N., Seifried, A., Custer, L. J., Chang, W., Lum-Jones, A., Donlon, T. (2001). Combined effects of well-done red meat, smoking, and rapid N-acetyltransferase 2 and CYP1A2 phenotypes in increasing colorectal cancer risk. Cancer Epidemiol. Biomark. Prev. 10:1259–1266. [CSA]
  • Lee, J. H., Chung, J. G., Lai, J. M., Levy, G. N., Weber, W. W. (1997). Kinetics of arylamine N-acetyltransferase in tissues from human breast cancer. Cancer Lett. 111:39–50. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Lee, E. J. D., Zhao, B., Seow-Choen, F. (1998). Relationship between polymorphism of N-acetyltransferase gene and susceptibility to colorectal carcinoma in a Chinese population. Pharmacogenetics 8:513–517. [PUBMED], [INFOTRIEVE], [CSA]
  • Lee, K. M., Park, S. K., Kim, S. U., Doll, M. A., Yoo, K. Y., Ahn, S. H., Noh, D. Y., Hirvonen, A., Hein, D. W., Kang, D. (2003). N-acetyltransferase (NAT1, NAT2) and glutathione S-transferase (GSTM1, GSTT1) polymorphisms in breast cancer. Cancer Lett. 196:179–186. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Leff, M. A., Epstein, P. N., Doll, M. A., Fretland, A. J., Devanboyina, U.-S., Rustan, T. D., Hein, D. W. (1999a). Prostate-specific human N-acetyltransferase 2 (NAT2) expression in the mouse. J. Pharmacol. Exp. Ther. 290:182–187. [PUBMED], [INFOTRIEVE], [CSA]
  • Leff, M. A., Fretland, A. J., Doll, M. A., Hein, D. W. (1999b). Novel human N-acetyltransferase 2 alleles that differ in mechanism for slow acetylator phenotype. J. Biol. Chem. 274:34519–34522. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Lemos, M. C., Regateiro, F. J. (1998). N-acetyltransferase genotypes in the Portugese population. Pharmacogenetics 8:561–564. [PUBMED], [INFOTRIEVE], [CSA]
  • Levy, G. N., Weber, W. W. (1992). 2-Aminofluorene-DNA adducts in mouse urinary bladder: effect of age, sex and acetylator phenotype. Carcinogenesis 13:159–164. [PUBMED], [INFOTRIEVE], [CSA]
  • Levy, G. N., Martell, K. J., Weber, W. W. (1993). Polymorphic N-acetylation of 2-aminofluorene by cell-free colon extracts from inbred mice. Pharmacogenetics 3:71–76. [PUBMED], [INFOTRIEVE], [CSA]
  • Levy, G. N., Chung, J.-G., Weber, W. W. (1994). 2-Aminofluorene metabolism and DNA adduct formation by mononuclear leukocytes from rapid and slow acetylator mouse strains. Carcinogenesis 15:353–357. [PUBMED], [INFOTRIEVE], [CSA]
  • Lin, H. J., Han, C. Y., Lin, B. K., Hardy, S. (1993). Slow acetylator mutations in the human polymorphic N-acetyltransferase gene in 786 Asians, blacks, Hispanics and whites: application to metabolic epidemiology. Am. J. Hum. Genet. 52:827–834. [PUBMED], [INFOTRIEVE], [CSA]
  • Lin, H. J., Han, C.-Y., Lin, B. K., Hardy, S. (1994). Ethnic distribution of slow acetylator mutations in the polymorphic N-acetyltransferase (NAT2) gene. Pharmacogenetics 4:125–134. [PUBMED], [INFOTRIEVE], [CSA]
  • Lin, H. J., Probst-Hensch, N. M., Hughes, N. C., Sakamoto, G. T., Louie, A. D., Kau, I. H., Lin, B. K., Lee, D. B., Lin, J., Frankl, H. D., Lee, E. R., Hardy, S., Grant, D. M., Haile, R. W. (1998). Variants of N-acetyltransferase NAT1 and a case-control study of colorectal adenomas. Pharmacogenetics 8:269–281. [PUBMED], [INFOTRIEVE], [CSA]
  • Lo-Guidice, J.-M., Allorge, D., Chevalier, D., Debuysère, H., Fazio, F., Lafitte, J.-J., Broly, F. (2000). Molecular analysis of the N-acetyltransferase 1 gene (NAT1*) using polymerase chain reaction-restriction fragment-single strand conformation polymorphism assay. Pharmacogenetics 10:293–300. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Macé, K., Bowman, E. D., Vautravers, P., Shields, P. G., Harris, C. C., Pfeifer, A. M. A. (1998). Characterisation of xenobiotic-metabolising enzyme expression in human bronchial mucosa and peripheral lung tissues. Eur. J. Cancer 34:914–920. [CSA], [CROSSREF]
  • Marcus, P. M., Vineis, P., Rothman, N. (2000a). NAT2 slow acetylation and bladder cancer risk: a meta-analysis of 22 case-control studies conducted in the general population. Pharmacogenetics 10:115–122. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Marcus, P. M., Hayes, R. B., Vineis, P., Garcia-Closas, M., Caporaso, N. E., Autrup, H., Branch, R. A., Brockmöller, J., Ishizaki, T., Karakaya, A. E., Ladero, J. M., Mommsen, S., Okkels, H., Romkes, M., Roots, I., Rothman, N. (2000b). Cigarette smoking, N-acetyltransferase 2 acetylation status, and bladder cancer risk: a case-series meta-analysis of a gene-environment interaction. Cancer Epidemiol. Biomark. Prev. 9:461–467. [CSA]
  • Martell, K. J., Levy, G. N., Weber, W. W. (1992). Cloned mouse N-acetyltransferases: enzymatic properties of expressed Nat-1 and Nat-2 gene products. Mol. Pharmacol. 42:265–272. [PUBMED], [INFOTRIEVE], [CSA]
  • Matas, N., Thygesen, P., Stacey, M., Risch, A., Sim, E. (1997). Mapping AAC1, AAC2 and AACP, the genes for arylamine N-acetyltransferases, carcinogen metabolising enzymes on human chromosome 8p22, a region frequently deleted in tumours. Cytogenet. Cell Genet. 77:290–295, [PUBMED], [INFOTRIEVE], [CSA]
  • Matheson, M. C., Stevenson, T., Akbarzadeh, S., Propert, D. N. (2002). GSTT1 null genotype increases risk of premenopausal breast cancer. Cancer Lett. 181:73–79. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Mattano, S. S., Erickson, R. P., Nesbitt, M. N., Weber, W. W. (1988). Linkage of Nat and Es-1 in the mouse and development of strains congenic for N-acetyltransferase. J. Heredity 79:430–433. [CSA]
  • McQueen, C. A., Mitchell, M. K., Dang, L. N., Chau, B., Tjalkens, R. B., Philbert, M. A. (2003). Prenatal expression of N-acetyltransferases in C57Bl/6 mice. Chem. Biol. Interact. 145:77–87. [PUBMED], [INFOTRIEVE], [CSA]
  • Millikan, R. C. (2000). NAT1*10 and NAT1*11 polymorphisms and breast cancer risk. Cancer Epidemiol. Biomark. Prev. 9:217–219. [CSA]
  • Millikan, R. C., Pittman, G. S., Newman, B., Tse, C.-K. J., Selmin, O., Rockhill, B., Savitz, D., Moorman, P. G., Bell, D. A. (1998). Cigarette smoking, N-acetyltransferases 1 and 2, and breast cancer risk. Cancer Epidemiol. Biomark. Prev. 7:371–378. [CSA]
  • Minchin, R. F. (1995). Acetylation of p-amino benzoylglutamate, a folic acid catabolite, by recombinant arylamine N-acetyltransferase and U937 cells. Biochem. J. 307:1–3. [PUBMED], [INFOTRIEVE], [CSA]
  • Minchin, R. F., Kadlubar, F. F., Ilett, K. F. (1993). Role of acetylation in colorectal cancer. Mutat. Res. 290:35–42. [PUBMED], [INFOTRIEVE], [CSA]
  • Mitchell, R. S., Bell, J. C. (1957). Clinical implications of isoniazid blood levels in pulmonary tuberculosis. New Engl. J. Med. 257:1066–1070. [PUBMED], [INFOTRIEVE], [CSA]
  • Mitchell, K. R., Warshawsky, D. (2003). Xenobiotic inducible regions of the human arylamine N-acetyltransferase 1 and 2 genes. Toxicol. Lett. 139:11–23. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Mitchell, M. K., Futscher, B. W., McQueen, C. A. (1999). Developmental expression of N-acetyltransferases in C57Bl/6 mice. Drug Metab. Dispos. 27:261–264. [PUBMED], [INFOTRIEVE], [CSA]
  • Mohrenweiser, H. W. (2004). Genetic variation and exposure related risk estimation: will toxicology enter a new era? DNA repair and cancer as a paradigm. Toxicol. Pathol. 32(Suppl. 1):136–145. [CSA], [CROSSREF]
  • Morabia, A., Bernstein, M. S., Bouchardy, I., Kurtz, J., Morris, M. A. (2000). Breast cancer and active and passive smoking: the role of the N-acetyltransferase 2 genotype. Am. J. Epidemiol. 152:226–232. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Mouse Genome Sequencing Consortium. (2002). Initial sequencing and comparative analysis of the mouse genome. Nature 420:520–562. [CSA], [CROSSREF]
  • Mrozikiewicz, P. M., Drakoulis, N., Roots, I. (1994). Polymorphic arylamine N-acetyltransferase (NAT2) genes in children with insulin-dependent diabetes mellitus. Clin. Pharmacol. Ther. 56:626–634. [PUBMED], [INFOTRIEVE], [CSA]
  • Mummidi, S., Ahuja, S. S., McDaniel, B. L., Ahuja, S. K. (1997). The human CC chemokine receptor 5 (CCR5) gene: multiple transcripts with 5′-end heterogeneity, dual promoter usage and evidence for polymorphisms within the regulatory regions and noncoding exons. J. Biol. Chem. 272:30662–30671. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Murtaugh, M. A., Ma, K. N., Sweeney, C., Caan, B. J., Slattery, M. L. (2004). Meat consumption patterns and preparation, genetic variants of metabolic enzymes, and their association with rectal cancer in men and women. J. Nutr. 134:776–784. [PUBMED], [INFOTRIEVE], [CSA]
  • Mushtaq, A., Payton, M., Sim, E. (2002). The COOH terminus of arylamine N-acetyltransferase from Salmonella typhimurium controls enzymatic activity. J. Biol. Chem. 277:12175–12181. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Nacak, M., Aynacioglu, A. S., Filiz, A., Cascorbi, I., Erdal, M. E., Yilmaz, N., Ekinci, E., Roots, I. (2002). Association between the N-acetylation genetic polymorphism and bronchial asthma. Br. J. Clin. Pharmacol. 54:671–674. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Nagao, M., Sugimura, T. (1993). Carcinogenic factors in food with relevance to colon cancer development. Mutat. Res. 290:43–51. [PUBMED], [INFOTRIEVE], [CSA]
  • Nagata, K., Ozawa, S., Miyata, M., Shimada, M., Yamazoe, Y., Kato, R. (1994). Primary structure and molecular basis of polymorphic appearance of an acetyltransferase (AT-II) in hamsters. Pharmacogenetics 4:91–100, [PUBMED], [INFOTRIEVE], [CSA]
  • Nakago, S., Hadfield, R. M., Zondervan, K. T., Mardon, H., Manek, S., Weeks, D. E., Barlow, D., Kennedy, S. (2001). Association between endometriosis and N-acetyltransferase 2 polymorphisms in a U.K. population. Mol. Hum. Reprod. 7:1079–1083. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Nebert, D. W. (1997). Polymorphisms in drug metabolising enzymes: what is their clinical relevance and why do they exist? Am. J. Hum. Genet. 60:265–271. [PUBMED], [INFOTRIEVE], [CSA]
  • Nelson, D. R., Koymans, L., Kamataki, T., Stegeman, J. J., Feyereisen, R., Waxman, D. J., Waterman, M. R., Gotoh, O., Coon, M. J., Estabrook, R. W., Gunsalus, I. C., Nebert, D. W. (1996). P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 6:1–42. [PUBMED], [INFOTRIEVE], [CSA]
  • Nyberg, F., Hou, S.-M., Hemminki, K., Lambert, B., Pershagen, G. (1998). Glutathione S-transferase μl and N-acetyltransferase 2 genetic polymorphisms and exposure to tobacco smoke in nonsmoking and smoking lung cancer patients and population controls. Cancer Epidemiol. Biomark. Prev. 7:875–883. [CSA]
  • O'Neil, W. M., Gilfix, B. M., DiGirolamo, A., Tsoukas, C. M., Wainer, I. (1997). N-acetylation among HIV-positive patients and patients with AIDS: when is fast, fast and slow, slow? Clin. Pharmacol. Ther. 62:261–271. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • O'Neil, W. M., MacArthur, R. D., Farrough, M. J., Doll, M. A., Fretland, A. J., Hein, D. W., Crane, L. R., Svensson, C. K. (2002). Acetylator phenotype and genotype in HIV-infected patients with and without sulfonamide hypersensitivity. J. Clin. Pharmacol. 42:613–619. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Ohsako, S., Deguchi, T. (1990). Cloning and expression of cDNAs for polymorphic and monomorphic arylamine N-acetyltransferases from human liver. J. Biol. Chem. 265:4630–4634. [PUBMED], [INFOTRIEVE], [CSA]
  • Ohsako, S., Ohtomi, M., Sakamoto, Y., Uyemura, K., Deguchi, T. (1988). Arylamine N-acetyltransferase from chicken liver: II. Cloning of cDNA and expression in Chinese hamster ovary cells. J. Biol. Chem. 263:7534–7538. [PUBMED], [INFOTRIEVE], [CSA]
  • Ohtomi, M., Sasaki, M., Deguchi, T. (1989). Two arylamine N-acetyltransferases from chicken pineal gland as identified by cDNA cloning. Eur. J. Biochem. 185:253–261. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Okkels, H., Sigsgaard, T., Wolf, H., Autrup, H. (1997). Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking. Cancer Epidemiol. Biomark. Prev. 6:225–231. [CSA]
  • Ono, K., Uzawa, K., Nakatsuru, M., Shiiba, M., Mochida, Y., Tada, A., Bukawa, H., Miyakawa, A., Yokoe, H., Tanzawa, H. (2003). Down-regulation of FEZ1/LZTS1 gene with frequent loss of heterozygosity in oral squamous cell carcinomas. Int. J. Oncol. 23:297–302. [PUBMED], [INFOTRIEVE], [CSA]
  • Pacifici, G. M., Bencini, C., Rane, A. (1986). Acetyltransferase in humans: development and tissue distribution. Pharmacology 32:283–291. [PUBMED], [INFOTRIEVE], [CSA]
  • Palmiter, R. D., Sandgren, E. P., Avarbock, M. R., Allen, D. D., Brinster, R. L. (1991). Heterologous introns can enhance expression of transgenes in mice. Proc. Natl. Acad. Sci. U. S. A. 88:478–482. [PUBMED], [INFOTRIEVE], [CSA]
  • Pawlik, A., Ostanek, L., Brzosko, I., Gawroska-Szklarz, B., Brzosko, M., Dabrowska-Zamojcin, E. (2002). Increased genotype frequency of N-acetyltransferase 2 slow acetylation in patients with rheumatoid arthritis. Clin. Pharmacol. Ther. 72:319–325. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Payton, M. A., Sim, E. (1998). Genotyping human arylamine N-acetyltransferase type 1 (NAT1): the identification of two novel allelic variants. Biochem. Pharmacol. 55:361–366. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Payton, M., Auty, R., Delgoda, R., Everett, M., Sim, E. (1999a). Cloning and characterisation of arylamine N-aetyltransferase genes from Mycobacterium smegmatis and Mycobacterium tuberculosis: increased expression results in isoniazid resistance. J. Bacteriol. 181:1343–1347. [PUBMED], [INFOTRIEVE], [CSA]
  • Payton, M., Smelt, V., Upton, A., Sim, E. (1999b). A method for genotyping murine arylamine N-acetyltransferase type 2 (NAT2): a gene expressed in preimplantation embryonic stem cells encoding an enzyme acetylating the folate catabolite p-aminobenzoylglutamate. Biochem. Pharmacol. 58:779–785, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Payton, M., Gifford, C., Schartau, P., Hagemeier, C., Mushtaq, A., Lucas, S., Pinter, K., Sim, E. (2001a). Evidence towards the role of arylamine N-acetyltransferase in Mycobacterium smegmatis and development of a specific antiserum against the homologous enzyme of Mycobacterium tuberculosis. Microbiology 147:3295–32302. [PUBMED], [INFOTRIEVE], [CSA]
  • Payton, M., Mushtaq, A., Yu, T.-W., Wu, L.-J., Sinclair, J., Sim, E. (2001b). Eubacterial arylamine N-acetyltransferases-identification and comparison of 18 members of the protein family with conserved active site cysteine, histidine and aspartate residues. Microbiology 147:1137–1147. [PUBMED], [INFOTRIEVE], [CSA]
  • Perou, C. M., Sørlie, T., Eisen, M., van de Rijnß, M., Jeffreyk, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., Fluge, E., Pergamenschikov, A., Williams, C., Zhuß, S. X., Lønning, P. E., Børresen-Dale, A.-L., Brown, P. O., Botstein, D. (2000). Molecular portraits of human breast tumours. Nature 406:747–752. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Pompeo, F., Mushtaq, A., Sim, E. Expression and purification of the rifamycin amide synthase, RifF, an enzyme homologous to the prokaryotic arylamine N-acetyltransferases. (2002). Protein Expr. Purif. 24:138–151. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Price-Evans, D. A., Manley, K. A., McKusick, V. A. (1960). Genetic control of isoniazid metabolism in man. Br. Med. J. 2:461–485. [CSA]
  • Probst-Hensch, N. M., Haile, R. W., Ingles, S. A., Longnecker, M. P., Han, C. Y., Lin, B. K., Lee, D. B., Sakamoto, G. T., Frankl, H. D., Lee, E. R. (1995). Acetylation polymorphism and prevalence of colorectal adenomas. Cancer Res. 55:2017–2020. [PUBMED], [INFOTRIEVE], [CSA]
  • Probst-Hensch, N. M., Haile, R. W., Li, D. S., Sakamoto, G. T., Louie, A. D., Lin, B. K., Frankl, H. D., Lee, E. R., Lin, H. J. (1996). Lack of association between the polyadenylation polymorphism in the NAT1 (acetyltransferase 1) gene and colorectal adenomas. Carcinogenesis 17:2125–2129. [PUBMED], [INFOTRIEVE], [CSA]
  • Rampazzo, A., Pivotto, F., Occhi, G., Tiso, N., Bortoluzzi, S., Rowen, L., Hood, L., Nava, A., Danieli, G. A. (2000). Characterisation of C14orf4, a novel intronless human gene containing a polyglutamine repeat, mapped to the ARVD1 critical region. Biochem. Biophys. Res. Commun. 278:766–774. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Rat Genome Sequencing Project Consortium. (2004). Genome sequence of the Brown Norway rat yields insights into mammalian evolution. Nature 428:493–521. [CSA], [CROSSREF]
  • Reeves, P. T., Minchin, R. F., Ilett, K. F. (1988). Induction of sulfamethazine acetylation by hydrocortisone in the rabbit. Drug Metab. Dispos. 16:110–115. [PUBMED], [INFOTRIEVE], [CSA]
  • Riddle, B., Jencks, W. P. (1971). Acetyl-coenzyme A: arylamine N-acetyltransferase; role of the acetyl-enzyme intermediate and the effects of substituents on the rate. J. Biol. Chem. 246:3250–3258. [PUBMED], [INFOTRIEVE], [CSA]
  • Risch, A., Wallace, D. M. A., Bathers, S., Sim, E. (1995). Slow acetylation genotype is a susceptibility factor in occupational and smoking related bladder cancer. Hum. Mol. Genet. 4:231–236. [PUBMED], [INFOTRIEVE], [CSA]
  • Rocha, L., Garcia, C., de Mendoca, A., Gil, J. P., Bishop, D. T., Lechner, M. C. (1999). N-acetyltransferase (NAT2) genotype and susceptibility to sporadic Alzheimer's disease. Pharmacogenetics 9:9–15. [PUBMED], [INFOTRIEVE], [CSA]
  • Rodriguez, J. W., Kirlin, W. G., Ferguson, R. J., Doll, M. A., Gray, K., Rustan, T. D., Kemp, K., Urso, P., Hein, D. W. (1993). Human acetylator genotype: relationship to colorectal cancer incidence and arylamine N-acetyltransferase expression in colon cytosol. Arch. Toxicol. 67:445–452. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Rodriguez-Lima, F., Dupret, J. M. (2002a). 3D model of human arylamine N-acetyltransferase 2: structural basis of the slow acetylator phenotype of the R64Q variant and analysis of the active-site loop. Biochem. Biophys. Res. Commun. 291:116–123. [CSA], [CROSSREF]
  • Rodriguez-Lima, F., Dupret, J. M. (2002b). In silico sequence analysis of arylamine N-acetyltransferases: evidence for an absence of lateral gene transfer from bacteria to vertebrates and first description of paralogs in bacteria. Biochem. Biophys. Res. Commun. 293:783–792, [CSA], [CROSSREF]
  • Rodriguez-Lima, F., Deloménie, C., Goodfellow, G. H., Grant, D. M., Dupret, J.-M. (2001). Homology modelling and structural analysis of human arylamine N-acetyltransferase NAT1. Evidence for the conservation of a cysteine protease catalytic domain and an active-site loop. Biochem. J. 356:327–334. [CSA]
  • Rodriguez-Lima, F., Cooper, R. N., Goudeau, B., Atmane, N., Chamagne, A. M., Butler-Browne, G., Vicart, E., Dupret, P. (2003). Skeletal muscles express the xenobiotic-metabolising enzyme arylamine N-acetyltransferase. J. Histochem. Cytochem. 51:789–796. [CSA]
  • Rogalla, P., Kazmierczak, B., Flohr, A. M., Hauke, S., Bullerdiek, J. (2000). Back to the roots of a new exon—the molecular archaeology of a SP100 splice variant. Genomics 63:117–122. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Rothman, N., Hayes, R. B., Bi, W., Caporaso, N., Broly, F., Woosley, R. L., Yin, S., Feng, P., You, X., Meyer, U. A. (1993). Correlation between N-acetyltransferase activity and NAT2 genotype in Chinese males. Pharmacogenetics 3:250–255. [PUBMED], [INFOTRIEVE], [CSA]
  • Rothman, N., Bhatnagar, V. K., Hayes, R. B., Zenser, T. V., Kashyap, S. K., Butler, M. A., Bell, D. A., Lakshmi, V., Jaeger, M., Kashyap, R., Hirvonen, A., Schulte, P. A., Dosemeci, M., Hsu, F., Parikh, D. J., Davis, B. B., Talaska, G. (1996). The impact of interindividual variation in NAT2 activity on benzidine urinary metabolites and urothelial DNA adducts in exposed workers. Proc. Natl. Acad. Sci. U. S. A. 93:5084–5089. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Rougraff, P. M., Paxton, R. (1987). Purification and partial characterisation of chicken liver acetyl coenzyme A:arylamine N-acetyltransferase. Comp. Biochem. Physiol. 86B:601–606. [CSA]
  • Sadrieh, N., Davis, C. D., Snyderwine, E. G. (1996). N-acetyltansferase expression and metabolic activation of the food-derived heterocyclic amines in the human mammary gland. Cancer Res. 56:2683–2687. [PUBMED], [INFOTRIEVE], [CSA]
  • Saito, K., Shinohara, A., Kamataki, T., Kato, R. (1985). Metabolic activation of mutagenic N-hydroxyarylamines by O-acetyltransferase in Salmonella typhimurium TA98. Arch. Biochem. Biophys. 239:286–295. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Salzberg, S. L., White, O., Peterson, J., Eisen, J. A. (2001). Microbial genes in the human genome: lateral transfer or gene loss? Science 292:1903–1906. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Sandy, J., Mushtaq, A., Kawamura, A., Sim, E., Noble, M. (2002). The structure of arylamine N-acetyltransferase from Mycobacterium smegmatis, an enzyme which inactivates the anti-tubercular drug isoniazid. J. Mol. Biol. 318:1071–1083. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Sandy, J., Holton, S., Fullam, E., Sim, E., Noble, M. (2005a). Binding of the anti-tubercular drug isoniazid to the arylamine N-acetyltransferase protein from Mycobacterium smagmatis. Protein Sci. 14:775–782. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Sandy, J., Mushtaq, A., Holton, S. J., Schartau P., Noble, M. E. M., Sim, E. (2005b). Investigationof the catalytic triad of arylamine N-acetyltransferases: essential residues required for acetyl transfer to arylamines. Biochem. J., Epub ahead of print. [CSA]
  • Sasaki, Y., Ohsako, S., Deguchi, T. (1991). Molecular and genetic analysis of arylamine N-acetyltransferase of rabbit liver. J. Biol. Chem. 266:13243–13250. [PUBMED], [INFOTRIEVE], [CSA]
  • Schnakenberg, E., Ehlers, C., Feyerabend, W., Werdin, R., Hubotter, R., Dreikorn, K., Schloot, W. (1998). Genotyping of the polymorphic N-acetyltransferase (NAT2) and loss of heterozygosity in bladder cancer patients. Clin. Genet. 53:396–402. [PUBMED], [INFOTRIEVE], [CSA]
  • Sekine, A., Saito, S., Iida, A., Mitsunobu, Y., Higuchi, S., Harigae, S., Nakamura, Y. (2001). Identification of single-nucleotide polymorphisms (SNPs) of human N-acetyltransferase genes NAT1, NAT2, AANAT, ARD1 and L1CAM in the Japanese population. J. Hum. Genet. 46:314–319. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Shibuta, K., Nakashima, T., Abe, M., Mashimo, M., Mori, M., Ueo, H., Akiyoshi, T., Sugimachi, K., Suzuki, T. (1994). Molecular genotyping for N-acetylation polymorphism in Japanese patients with colorectal cancer. Cancer 74:3108–3112. [PUBMED], [INFOTRIEVE], [CSA]
  • Shishikura, K., Hohjoh, H., Tokunaga, K. (2000). Novel allele containing a 190C > T nonsynonymous substitution in the N-acetyltransferase (NAT2) gene. Human Mutat. 5:581. [CSA]
  • Sim, E., Hickman, D. (1991). Polymorphism in human N-acetyltransferase—the case of the missing allele. Trends Pharmacol. Sci. 12:211–213. [CSA], [CROSSREF]
  • Sim, E., Stanley, L. A., Risch, A., Thygesen, P. (1995). Xenogenetics in multifactorial disease susceptibility. Trends Genet. 11:509–512. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Sim, E., Pinter, K., Mushtaq, A., Upton, A., Sandy, J., Bhakta, S., Noble, M. (2003). Arylamine N-acetyltransferases: a pharmacogenomic approach to drug metabolism and endogenous function. Biochem. Soc. Trans. 31:615–619. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Sinclair, J. C., Sim, E. (1997). A fragment consisting of the first 204 amino-terminal amino acids of human arylamine N-acetyltransferase one (NAT1) and the first transacetylation step of catalysis. Biochem. Pharmacol. 53:11–16. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Sinclair, J. C., Sandy, J., Delgoda, R., Sim, E., Noble, M. E. M. (2000). Structure of arylamine N-acetyltransferase reveals a catalytic triad. Nat. Struct. Biol. 7:560–564. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Slattery, M. L., Curtin, K., Ma, K., Schaffer, D., Potter, J., Samowitz, W. (2002). GSTM-1 and NAT2 and genetic alterations in colon tumours. Cancer Causes Control 13:527–534. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Smelt, V. A., Mardon, H. J., Sim, E. (1998). Placental expression of arylamine N-acetyltransferases: evidence for linkage disequilibrium between NAT1*10 and NAT2*4 alleles of the two human arylamine N-acetyltransferase loci NAT1 and NAT2. Pharmacol. Toxicol. 83:149–157. [PUBMED], [INFOTRIEVE], [CSA]
  • Smelt, V. A., Upton, A., Adjaye, J., Payton, M. A., Boukouvala, S., Johnson, N., Mardon, H. J., Sim, E. (2000). Expression of arylamine N-acetyltransferases in pre-term placentas and in human pre-implantation embryos. Hum. Mol. Genet. 9:1101–1107. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Smith, C. W. J., Patton, J. G., Nadal-Ginard, B. (1989). Alternative splicing in the control of gene expression. Annu. Rev. Genet. 23:527–577. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Smith, C. A. D., Wadelius, M., Gough, A. C., Harrison, D. J., Wolf, C. R., Rane, A. (1997). A simplified assay for the arylamine N-acetyltransferase 2 polymorphism validated by phenotyping with isoniazid. J. Med. Genet. 34:758–760. [PUBMED], [INFOTRIEVE], [CSA]
  • Smolen, T. N., Brewer, J. A., Weber, W. W. (1993). Testosterone modulation of N-acetylation in mouse kidney. J. Pharmacol. Exp. Ther. 264:854–858. [PUBMED], [INFOTRIEVE], [CSA]
  • Sonenberg, N. (1994). mRNA translation: influence of the 5′ and 3′ untranslated regions. Curr. Opin. Genet. Dev. 4:310–315. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Sosinsky, A., Glusman, G., Lancet, D. (2000). The genomic structure of human olfactory receptor genes. Genomics 70:49–61. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Spurr, N. K., Gough, A. C., Chinegwundoh, F. I., Smith, C. A. (1995). Polymorphisms in drug-metabolising enzymes as modifiers of cancer risk. Clin. Chem. 41:1864–1869. [PUBMED], [INFOTRIEVE], [CSA]
  • Stacey, M., Matas, N., Drake, M., Payton, M., Fakis, G., Greenland, J., Sim, E. (1999). Arylamine N-acetyltransferase type 2 (NAT2), chromosome 8 aneuploidy, and identification of a novel NAT1 cosmid clone: an investigation in bladder cancer by interphase FISH. Genes, Chromosomes Cancer 25:376–383. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Stanley, L. A., Coroneos, E., Cuff, R., Hickman, D., Ward, A., Sim, E. (1996). Immunochemical detection of arylamine N-acetyltransferase in normal and neoplastic bladder. J. Histochem. Cytochem. 44:1059–1067. [PUBMED], [INFOTRIEVE], [CSA]
  • Stanley, L. A., Mills, I. G., Sim, E. (1997). Localisation of polymorphic N-acetyltransferase (NAT2) in tissues of inbred mice. Pharmacogenetics 7:121–130. [PUBMED], [INFOTRIEVE], [CSA]
  • Stanley, L. A., Copp, A. J., Pope, J., Rolls, S., Smelt, V., Perry, V. H., Sim, E. (1998). Immunochemical detection of arylamine N-acetyltransferase during mouse embryonic development and in adult mouse brain. Teratology 58:174–182. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Sugamori, K. S., Wong, S., Gaedigk, A., Yu, V., Abramovici, H., Rozmahel, R., Grant, D. M. (2003). Generation and functional characterization of arylamine N-acetyltransferase Nat1/Nat2 double-knockout mice. Mol. Pharmacol. 64:170–179. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Sugamori, K. S., Wong, S., Brenneman, D., Lu, X., Grant, D. M. (2004). NAT3 knockout or overexpression in mice has no influence on N-acetylation activity. Drug Metab. Rev. 36(Suppl.):164, [CSA]
  • Summerscales, J. E., Josephy, P. D. (2004). Human acetyl CoA:arylamine N-acetyltransferase variants generated by random mutagenesis. Mol. Pharmacol. 65:220–226. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Taylor, J. A., Umbach, D. M., Stephens, E., Castranio, T., Paulson, D., Robertson, C., Mohler, J. L., Bell, D. A. (1998). The role of N-acetylation polymorphisms in smoking-associated bladder cancer: evidence of a gene–gene-exposure three-way interaction. Cancer Res. 58:3603–3610. [PUBMED], [INFOTRIEVE], [CSA]
  • Thygesen, P., Risch, A., Stacey, M., Fakis, G., Takle, L., Knowles, M., Sim, E. (1999). Genes for arylamine N-acetyltransferases in relation to loss of the short arm of chromosome 8 in bladder cancer. Pharmacogenetics 9:1–8. [PUBMED], [INFOTRIEVE], [CSA]
  • Tiemersma, E. W., Kampman, E., Bueno de Mesquita, H. B., Bunschoten, A., van Schothorst, E. M., Kok, F. J., Kromhout, D. (2002). Meat consumption, cigarette smoking, and genetic susceptibility in the etiology of colorectal cancer: results from a Dutch prospective study. Cancer Causes Control 13:383–393. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Trepanier, L. A., Ray, K., Winand, N. J., Spielberg, S. P., Cribb, A. E. (1997). Cytosolic arylamine N-acetyltransferase (NAT) deficiency in the dog and other canids due to an absence of NAT genes. Biochem. Pharmacol. 54:73–80. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Trepanier, L. A., Cribb, A., Spielberg, S. P., Ray, K. (1998). Deficiency of cytosolic arylamine N-acetylation in the domestic cat and wild felids caused by the presence of a single NAT1-like gene. Pharmacogenetics 8:169–179. [PUBMED], [INFOTRIEVE], [CSA]
  • Tsou, M. F., Chung, J. G., Wu, L. T., Cheng, K. S., Hung, C. F. (1998). Characterisation of arylamine N-acetyltransferase in Enterobacter aerogenes. Microbios 94:133–143. [PUBMED], [INFOTRIEVE], [CSA]
  • Tsou, M. F., Hung, C. F., Lu, H. F., Wu, L. T., Chang, S. H., Chang, H. L., Chen, G. W., Chung, J. G. (2000). Effects of caffeic acid, chlorogenic acid and ferulic acid on growth and arylamine N-acetyltransferase activity in Shigella sonnei (group D). Microbios 101:37–46. [PUBMED], [INFOTRIEVE], [CSA]
  • Tsukino, H., Kuroda, Y., Nakao, H., Imai, H., Inatomi, H., Osda, Y., Katoh, T. (2004). Cytochrome P450 (CYP) 1A2, sulfotransferase (SULT) 1A1 and N-acetyltransferase (NAT) 2 polymorphisms and susceptibility to urothelial cancer. J. Cancer Res. Clin. Oncol. 130:99–106. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Upton, A., Smelt, V., Mushtaq, A., Aplin, R., Johnson, N., Mardon, H., Sim, E. (2000). Placental arylamine N-acetyltransferase type 1: potential contributory source of urinary folate catabolite p-acetamidobenzoylglutamate during pregnancy. Biochim. Biophys. Acta 1524:143–148. [PUBMED], [INFOTRIEVE], [CSA]
  • Upton, A., Johnson, N., Sandy, J., Sim, E. (2001a). Arylamine N-acetyltransferases—of mice, men and microorganisms. Trends Pharmacol. Sci. 22:140–146. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Upton, A. M., Mushtaq, A., Victor, T. C., Sampson, S. L., Sandy, J., Smith, D.-M., van Helden, P. V., Sim, E. (2001b). Arylamine N-acetyltransferase of Mycobacterium tuberculosis is a polymorphic enzyme and a site of isoniazid metabolism. Mol. Microbiol. 42:309–317. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Van der Hel, O. L., Peeters, P. H., Hein, D. W., Grobbee, M. A., Ocke, D. E., Bueno de Mesquita, M. (2004). GSTM1 null genotype, red meat consumption and breast cancer risk (The Netherlands). Cancer Causes Control 15:295–303. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Van der Walt, J. M., Martin, E. R., Scott, W. K., Zhang, F., Nance, M. A., Watts, R. L., Hubble, J. P., Haines, J. L., Koller, W. C., Lyons, K., Pahwa, R., Stern, M. B., Colcher, A., Hiner, B. C., Jankovic, J., Ondo, W. G., Allen, F. H. Jr., Koller, W. C., Lyons, K., Pahwa, R., Stern, M. B., Colcher, A., Hiner, B. C., Jankovic, J., Ondo, W. G., Allen, F. H. Jr., Goetz, C. G., Small, G. W., Mastaglia, F., Roses, A. D., Stajich, J. M., Booze, M. W., Fujiwara, K., Gibson, R. A., Middleton, L. T., Scott, B. L., Pericak-Vance, M. A., Vance, J. M. (2003). Genetic polymorphisms of the N-acetyltransferase genes and risk of Parkinson's disease. Neurology 60:1189–1191. [PUBMED], [INFOTRIEVE], [CSA]
  • Vatsis, K. P., Weber, W. W. (1993). Structural heterogeneity of Caucasian N-acetyltranferase at the NAT1 gene locus. Arch. Biochem. Biophys. 301:71–76. [PUBMED], [INFOTRIEVE], [CSA]
  • Vatsis, K. P., Martell, K. J., Weber, W. W. (1991). Diverse point mutations in the human gene for polymorphic N-acetyltransferase. Proc. Natl. Acad. Sci. U. S. A. 88:6333–6337, [PUBMED], [INFOTRIEVE], [CSA]
  • Vatsis, K. P., Weber, W. W., Bell, D. A., Dupret, J.-M., Price-Evans, D. A., Grant, D. M., Hein, D. W., Lin, H. J., Meyer, U. A., Relling, M. V., Sim, E., Suzuki, T., Yamazoe, Y. (1995). Nomenclature for N-acetyltransferases. Pharmacogenetics 5:1–17. [PUBMED], [INFOTRIEVE], [CSA]
  • Vaziri, S. J., Hughes, N. C., Sampson, H., Darlington, G., Jewett, M. A. S., Grant, D. M. (2001). Variation in enzymes of arylamine procarcinogen biotransformation among bladder cancer patients and control subjects. Pharmacogenetics 11:7–20. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Vineis, P., Bartsch, H., Caporaso, N., Harrington, A. M., Kadlubar, F. F., Landi, M. T., Malaveille, C., Shields, P. G., Skipper, P., Talaska, G., Tannenbaum, S. R. (1994). Genetically based N-acetyltransferase metabolic polymorphism and low-level environmental exposure to carcinogens. Nature 369:154–156. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Vineis, P., Marinelli, D., Autrup, H., Brockmöller, J., Cascorbi, I., Daly, A. K., Golka, K., Okkels, H., Risch, A., Rothman, N., Sim, E., Taioli, E. (2001). Current smoking, occupation, N-acetyltransferase-2 and bladder cancer: a pooled analysis of genotype-based studies. Cancer Epidemiol. Biomark. Prev. 10:1249–1252. [CSA]
  • Wadelius, M., Autrup, J. L., Stubbins, M. J., Andersson, S.-O., Johansson, J.-E., Wadelius, C., Wolf, C. R., Autrup, H., Rane, A. (1999). Polymorphisms in NAT2, CYP2D6, CYP2C19 and GSTP1 and their association with prostate cancer. Pharmacogenetics 9:333–340. [PUBMED], [INFOTRIEVE], [CSA]
  • Wang, J. C., Radford, D. M., Holt, M. S., Helms, C., Goate, A., Brandt, W., Parik, M., Phillips, N. J., DeSchyver, K., Schuh, M. E., Fair, K. L., Ritter, J. H., Marshall, P., Donnis-Keller, H. (1999). Sequence-ready contig for the 1.4-cM ductal carcinoma in situ loss of heterozygocity region on chromosome 8p22–p23. Genomics 60:1–11. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Wang, H., Vath, G. M., Gleason, K. J., Hanna, P. E., Wagner, C. R. (2004). Probing the mechanism of hamster arylamine N-acetyltransferase 2 acetylation by active site modification, site-directed mutagenesis, and pre-steady state and steady state kinetic studies. Biochemistry 43:8234–8246. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Ward, A., Hickman, D., Gordon, J. W., Sim, E. (1992). Arylamine N-acetyltransferase in human red blood cells. Biochem. Pharmacol. 44:1099–1104. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Ward, A., Summers, M. J., Sim, E. (1995). Purification of recombinant human N-acetyltransferase type 1 (NAT1) expressed in E. coli and characterisation of its potential role in folate metabolism. Biochem. Pharmacol. 49:1759–1767. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Ware, J. A., Svensson, C. K. (1996). Longitudinal distribution of arylamine N-acetyltransferases in the intestine of the hamster, mouse, and rat. Biochem. Pharmacol. 52:1613–1620. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Watanabe, M., Ishidate, M. Jr, Nohmi, T. (1990). Sensitive method for the detection of mutagenic nitroarenes and aromatic amines: new derivatives of Salmonella typhimurium tester strains possessing elevated O-acetyltreansferase levels. Mutat. Res. 234:337–348. [PUBMED], [INFOTRIEVE], [CSA]
  • Watanabe, M., Sofuni, T., Nohmi, T. (1992). Involvement of Cys69 residue in the catalytic mechanism of N-hydroxyarylamine O-acetyltransferase of Salmonella typhimurium. Sequence similarity at the amino acid level suggests a common catalytic mechanism of acetyltransferase for S. typhimurium and higher organisms. J. Biol. Chem. 267:8429–8436. [PUBMED], [INFOTRIEVE], [CSA]
  • Weber, W. W., Cohen, S. N. (1967). N-acetylation of drugs: isolation and properties of an N-acetyltransferase from rabbit liver. Mol. Pharmacol. 3:266–273. [PUBMED], [INFOTRIEVE], [CSA]
  • Weber, W. W., Hein, D. W. (1985). N-acetylation pharmacogenetics. Pharmacol. Rev. 37:25–78. [PUBMED], [INFOTRIEVE], [CSA]
  • Weisburger, J. H. (1997). A perspective on the history and significance of carcinogenic and mutagenic N-substituted aryl compounds in human health. Mutat. Res. 376:261–266. [PUBMED], [INFOTRIEVE], [CSA]
  • Welfare, M. R., Cooper, J., Bassendine, M. F., Daly, A. K. (1997). Relationship between acetylator status, smoking and diet and colorectal cancer risk in the north-east of England. Carcinogenesis 18:1351–1354. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Westphal, G. A., Reich, K., Schultz, T. G., Neumann, C., Hallier, E., Schnuch, A. (2000). N-acetyltransferase 1 and 2 polymorphisms in para-substituted arylamine-induced contact allergy. Br. J. Dermatol. 142:1121–1127. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Westwood, I. M., Holton, S. J., Rodriguez-Lima, F., Dupret, J. M., Bhakta, S., Noble, M. E., Sim, E. (2005). Expression, purification, characterization and structure of Pseudomonas aeruginosa arylamine N-acetyltransferase. Biochem. J. 385:605–612. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Wikman, H., Thiel, S., Jäger, B., Schmezer, P., Spiegelhalder, B., Edler, L., Dienemann, H., Kayser, H., Schulz, V., Drings, P., Bartsch, H., Risch, A. (2001). Relevance of N-acetyltranferase 1 and 2 (NAT1, NAT2) genetic polymorphisms in non-small cell lung cancer susceptibility. Pharmacogenetics 11:157–168. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Williams, J. A., Phillips, D. H. (2000). Mammary expression of xenobiotic metabolising enzymes and their potential role in breast cancer. Cancer Res. 60:4667–4677. [PUBMED], [INFOTRIEVE], [CSA]
  • Williams, J. A., Stone, A. M., Fakis, G., Johnson, N., Cordell, J. A., Meinl, W., Glatt, H., Sim, E., Phillips, D. H. (2001). N-acetyltransferases, sulfotransferases and heterocyclic amine activation in the breast. Pharmacogenetics 11:371–388. [CSA], [CROSSREF]
  • Windmill, K. F., McKinnon, R. A., Zhu, X., Gaedigk, A., Grant, D. M., McManus, M. E. (1997). The role of xenobiotic metabolising enzymes in arylamine toxicity and carcinogenesis: functional and localisation studies. Mutat. Res. 376:153–160. [PUBMED], [INFOTRIEVE], [CSA]
  • Wong, L.-L. (1998). Cytochrome P450 monooxygenases. Curr. Opin. Chem. Biol. 2:263–268. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Woolhouse, N. M., Qureshi, M. M., Bastaki, S. M. A., Patel, M., Abdulrazzaq, Y., Bayoumi, A. L. (1997). Polymorphic N-acetyltransferase (NAT2) genotyping of Emiratis. Pharmacogenetics 7:73–82. [PUBMED], [INFOTRIEVE], [CSA]
  • Yang, M., Katoh, T., Delongchamp, R., Ozawa, S., Kohshi, K., Kawamoto, T. (2000). Relationship between NAT1 genotype and phenotype in a Japanese population. Pharmacogenetics 10:225–232. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Ye, Z., Parry, J. M. (2002). Meta-analysis of 20 case-control studies on the N-acetyltransferase 2 acetylation status and colorectal cancer risk. Med. Sci. Monit. 8:CR558–CR565. [PUBMED], [INFOTRIEVE], [CSA]
  • Zaher, H., Svensson, C. K. (1994). Glucocorticoid induction of hepatic acetyl CoA:arylamine N-acetyltransferase activity in the rat. Res. Commun. Chem. Pathol. Pharmacol. 83:195–208. [PUBMED], [INFOTRIEVE], [CSA]
  • Zenser, T. V., Lakshmi, V. M., Rustan, T. D., Doll, M. A., Deitz, A. C., Davies, B. B., Hein, D. W. (1996). Human N-acetylation of benzidine: role of NAT1 and NAT2. Cancer Res. 56:3941–3947. [PUBMED], [INFOTRIEVE], [CSA]
  • Zhao, B., Lee, E., Yeoh, P. N., Gong, N. H. (1998). Detection of mutations and polymorphism of N-acetyltransferase 1 gene in Indian, Malay and Chinese populations. Pharmacogenetics 8:299–304. [PUBMED], [INFOTRIEVE], [CSA]
  • Zheng, W., Deitz, A. C., Campbell, D. R., Wen, W.-Q., Cerhan, J. R., Sellers, T. A., Folsom, A. R., Hein, D. W. (1999). N-acetyltransferase 1 genetic polymorphism, cigarette smoking, well-done meat intake and breast cancer risk. Cancer Epidemiol. Biomark. Prev. 8:233–239. [CSA]
  • Zhou, W., Liu, G., Thurston, S. W., Xu, L. L., Miller, D. P., Wain, J. C., Lynch, T. J., Su, L., Christiani, D. C. (2002). Genetic polymorphisms in N-acetyltransferase-2 and microsomal epoxide hydrolase, cumulative cigarette smoking and lung cancer. Cancer Epidemiol. Biomark. Prev. 11:15–21. [CSA]
  • Zschieschang, P., Hiepe, F., Gromnica-Ihle, E., Roots, I., Cascorbi, I. (2002). Lack of association between arylamine N-acetyltransferase 2 (NAT2) polymorphism and systemic lupus erythematosus. Pharmacogenetics 12:559–563. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.